VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 6255 · 111th Congress

To require mail-order pharmacies to notify customers when generic drugs become available and to prevent…

Full title

To require mail-order pharmacies to notify customers when generic drugs become available and to prevent mail-order pharmacies from substituting drugs without the express authorization of the prescriber.

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

No cosponsors.

Requires a mail-order pharmacy to inform a customer to whom it dispenses a prescription brand name drug when a generic drug that is the pharmaceutical equivalent becomes available.

What it does: CRS summary · Introduced in House · Sep 29, 2010

Requires a mail-order pharmacy to inform a customer to whom it dispenses a prescription brand name drug when a generic drug that is the pharmaceutical equivalent becomes available.

Permits a mail-order pharmacy to substitute a generic drug for a brand name drug or a brand name drug for a generic drug if the mail order pharmacy: (1) notifies the customer that the pharmacy will request that the prescriber provide an authorization to make such a substitution; and (2) after providing such notification, obtains the express written authorization of the prescriber of the drug to make such a substitution. Requires the prescriber to provide notice to the customer of an authorization.

Permits the Secretary of Health and Human Services (HHS) to assess civil penalties against a mail-order pharmacy for violations of this Act.

Declares that this Act preempts state laws to the extent any are inconsistent with this Act.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: To require mail-order pharmacies to notify customers when generic drugs become available and to prevent mail-order pharmacies from substituting drugs without the express authorization of the prescriber.

Latest action (Sep 29, 2010): Referred to the House Committee on Energy and Commerce.

Policy area: Commerce · Origin: House · Introduced: Sep 29, 2010

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.